Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection-Reference-Cited by-同舟云学术

Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection

Published:2017-02 Issue:2 Volume:144 Page:266-273
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Gill Sarah E.,McGree Michaela E.,Weaver Amy L.,Cliby William A.,Langstraat Carrie L.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference42 articles.

1. Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study;Bertelsen;Gynecol. Oncol.,1990

2. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma;Griffiths;Natl. Cancer Inst. Monogr.,1975

3. Intensive surgical and chemotherapeutic management of advanced ovarian cancer;Griffiths;Surg. Clin. North Am.,1978

4. Primary cytoreductive surgery for epithelial ovarian cancer;Hacker;Obstet. Gynecol.,1983

5. Stage III epithelial ovarian cancer: the role of maximal surgical reduction;Delgado;Gynecol. Oncol.,1984

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics, Treatment Patterns and Survival of International Federation of Gynecology and Obstetrics Stage IV Epithelial Ovarian Cancer—A Population-Based Study;Cancers;2023-11-30

2. A retrospective analysis for investigating the relationship between FIGO stage IVA/IVB and cytoreductive surgery with prognosis in epithelial ovarian cancer;Frontiers in Oncology;2023-07-24

3. Next Steps Toward Reducing Surgical Morbidity After Complex Cytoreductive Surgery in Fit Surgical Patients;Journal of Gynecologic Surgery;2023-06-01

4. The feasibility of screening for malnutrition in the outpatient setting and the prevalence of malnutrition in patients with newly-diagnosed ovarian carcinoma;Gynecologic Oncology Reports;2022-10

5. Surgery in Advanced Ovary Cancer: Primary versus Interval Cytoreduction;Diagnostics;2022-04-14